Strategies to Improve Vaccination among At-Risk Adults and the Elderly in Italy

Giovanna Elisa Calabrò, Alessia Tognetto, Elettra Carini, Silvia Mancinelli, Laura Sarnari, Vittoria Colamesta, Walter Ricciardi, Chiara de Waure, Giovanna Elisa Calabrò, Alessia Tognetto, Elettra Carini, Silvia Mancinelli, Laura Sarnari, Vittoria Colamesta, Walter Ricciardi, Chiara de Waure

Abstract

The World Health Organization (WHO), the United States (US) Centers for Disease Control and Prevention (CDC), the European Center for Disease Control (ECDC), and the immunization guidelines of many countries issue vaccination recommendations for adults and the elderly. However, the uptake of vaccination in these groups is generally low due to several reasons. The present study aimed to identify strategies implemented in Italy in unconventional settings to promote vaccination against influenza, pneumococcal, and herpes zoster virus (HZV) infections among these subjects, i.e., the at-risk adult population and the elderly. We conducted a literature review and a survey of experts. The literature search yielded seven strategies; all of these concerned influenza vaccination, while three also addressed pneumococcal and HZV vaccination. The survey of experts identified 15 strategies; 10 regarded influenza vaccination, while four regarded pneumococcal vaccination and one regarded HZV vaccination. Most of the strategies were implemented in hospital clinics and rest homes. Regarding influenza and pneumococcal vaccinations, the target population mainly comprised at-risk adults, while the elderly represented the main target population for HZV vaccination. Our results show that, in Italy, there are initiatives aimed at promoting vaccination in unconventional settings, but further efforts are required to assess their effectiveness and to further extend them.

Keywords: HZV vaccination; elderly; immunization strategies; influenza vaccination; pneumococcal vaccination.

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. World Health Organization Immunization Coverage. [(accessed on 11 April 2020)]; Available online: .
    1. Janssens J.P. Pneumonia in the elderly (geriatric) population. Curr. Opin. Pulm. Med. 2005;11:226–230. doi: 10.1097/01.mcp.0000158254.90483.1f.
    1. Pera A., Campos C., López N., Hassouneh F., Alonso C., Tarazona R., Solana R. Immunosenescence: Implications for response to infection and vaccination in older people. Maturitas. 2015;82:50–55. doi: 10.1016/j.maturitas.2015.05.004.
    1. Special Eurobarometer 488 Europeans’ Attitudes towards Vaccination. [(accessed on 13 April 2019)]; Available online: .
    1. Coll P.P., Costello V.W., Kuchel G.A., Bartley J., McElhaney J.E. The Prevention of Infections in Older Adults: Vaccination. J. Am. Geriatr. Soc. 2020;68:207–214. doi: 10.1111/jgs.16205.
    1. Esposito S., Principi N., Rezza G., Bonanni P., Gavazzi G., Beyer I., Sulzner M., Celentano L.P., Prymula R., Rappagliosi A., et al. WAidid-EVASG Panel on vaccination of 50+. Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward. Vaccine. 2018;36:5819–5824. doi: 10.1016/j.vaccine.2018.08.041.
    1. World Health Organization WHO Recommendations for Routine Immunization—Summary Tables. [(accessed on 13 April 2020)]; Available online:
    1. Centers for Disease Control and Prevention Vaccine Information for Adults. [(accessed on 13 April 2020)]; Available online: .
    1. European Centre for Disease Control Vaccine Schedules in All Countries of the European Union. [(accessed on 13 April 2020)]; Available online:
    1. European Centre for Disease Prevention and Control Vaccine Schedule. [(accessed on 13 April 2019)]; Available online: .
    1. Italian Health Ministry National Preventive Vaccination Plan 2017–2019. [(accessed on 13 April 2020)]; Available online: .
    1. Italian Health Ministry Vaccination Coverage. Influenza. [(accessed on 13 April 2020)]; Available online: .
    1. World Health Organization Improving Vaccination Demand and Addressing Hesitancy. [(accessed on 13 April 2020)]; Available online:
    1. World Health Organization Report of the Sage Working Group on Vaccine Hesitancy. [(accessed on 13 April 2020)]; Available online: .
    1. European Centre for Disease Prevention and Control Catalogue of Interventions Addressing Vaccine Hesitancy. [(accessed on 13 April 2020)]; Available online: .
    1. World Healh Organization Increasing Vaccination Model. [(accessed on 13 April 2020)]; Available online: .
    1. Betsch C., Schmid P., Heinemeier D., Korn L., Holtmann C., Böhm R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE. 2018;13:e0208601. doi: 10.1371/journal.pone.0208601.
    1. Ozawa S., Portnoy A., Getaneh H., Clark S., Knoll M., Bishai D., Yang H.K., Patwardhan P.D. Modeling the economic burden of adult vaccine-preventable diseases in the United States. Health Aff. 2016;35:2124–2132. doi: 10.1377/hlthaff.2016.0462.
    1. European Center for Disease Control (ECDC) Low Uptake of Seasonal Influenza Vaccination in Europe May Jeopardize Capacity to Protect People in Next Pandemic. [(accessed on 13 April 2020)]; Available online: .
    1. Audisio R., Icardi G., Isidori A.M., Liverani C., Lombardi A., Mariani L., Mennini F.S., Mitchell D.A., Peracino A., Pecorelli S., et al. Public health value of universal HPV vaccination. Crit. Rev. Oncol. Hematol. 2016;97:157–167. doi: 10.1016/j.critrevonc.2015.07.015.
    1. Nymark L.S., Sharma T., Miller A., Enemark U., Griffiths U.K. Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used. Vaccine. 2017;35:6828–6841. doi: 10.1016/j.vaccine.2017.10.024.
    1. United Nations World Population Prospects: The 2017 Revision. [(accessed on 13 April 2020)]; Available online: .

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner